DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / T••••••• V•••••• M••••••••• L••
T••••••• V•••••• M••••••••• L••
Micro VC · probableSan Antonio, TXt•••••••••.comSEC exempt reporting adviserone firm, 2 filing advisers
This firm files as 2 advisers on t•••••••••.com: I••••• V•••••• M••••••••• L••. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
venture manager, reported GAV $28.1M across 3 vehicles
Importance
12
low
Active deployment
0
low
Emerging
0
low
Completeness
75
high
Freshness
99
high
Research priority
2
low
Identity and regulatory footprint
- Headquarters
- San Antonio, TXadviserinfo.sec.gov
- Office address
- 4725 COLLEGE PARK, SUITE 200, San Antonio, TX, 78249adviserinfo.sec.gov
- Business phone
- 210-667-7920adviserinfo.sec.gov
- Website
- t•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Mar 23, 2023
- Private funds reported
- 3 (3 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $28.1Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- P••• C•••••••• L•• (Partner), F; P••• C••••••• F••••• L•••••• P••••••••• (Member), C
- business email
- info@targetedtech.comtargetedtech.compublished by the subject
- business phone
- 210-667-7920adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, medtech
- Stages
- early
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
Biotechnology 100%
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
3 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| T••••••• J•• A•••••••• F•••• L• | Feeder or parallel | 2015 adv first reported | Harvest | $14.1M Mar 23, 2023 | 86 | unknown | unknown |
| T••••••• C••••• F••• I• L• | Fund | 2015 adv first reported | Harvest | $0 Mar 23, 2023 | 2 | unknown | unknown |
| T••••••• T••••••••• F••• I•• L• | Fund | 2013 form d first sale | Harvest | $14.1M Mar 23, 2023 | 84 | $37.2M of $50.0M | Oct 15, 2014 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
6 current, 5 departed
A••• D•••
Managing partnerSenior Managing Partner
A••• H• D•••
PartnerMember · since Oct 1, 2013
C•••• L•••••••
PartnerMember · since Oct 1, 2013
I•• C•••••••
PartnerMember · since Oct 1, 2013
J•••• F• T•••
PartnerMember · since Oct 1, 2013
P••• C•••••••
PartnerPartner · since Feb 1, 2010
5 departed (kept with end dates)
- C•••••••• M• B••••• · Member · Jan 1, 2012 to Mar 29, 2018 Inference
- F•••••• N• B••••• · Member · Jan 1, 2012 to Mar 29, 2018 Inference
- G••• E• F••••••• · Member · Dec 1, 2000 to Mar 29, 2018 Inference
- G••• H• F••••••• · Partner · Nov 1, 2005 to Mar 29, 2018 Inference
- P•••• S•••• · Member · Oct 1, 2013 to Mar 28, 2019 Inference
Investments on record
1 edges, 1 companies, 1 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| H••• B••••••• I••• | board seat | unknown · board | P••• C••••••• (strongly supported) | unknown | unknown | Aug 12, 2024 | Inference SEC EDGAR Form D data sets (quarterly) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
1 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
- Mar 28, 2019P•••• S•••• (Member) no longer on Schedule A of T••••••• V•••••• M••••••••• L••
- Mar 29, 2018G••• H• F••••••• (Partner) no longer on Schedule A of T••••••• V•••••• M••••••••• L••
- Mar 29, 2018C•••••••• M• B••••• (Member) no longer on Schedule A of T••••••• V•••••• M••••••••• L••
- Mar 29, 2018F•••••• N• B••••• (Member) no longer on Schedule A of T••••••• V•••••• M••••••••• L••
- Mar 29, 2018G••• E• F••••••• (Member) no longer on Schedule A of T••••••• V•••••• M••••••••• L••
- Mar 31, 2015T••••••• J•• A•••••••• F•••• L• first reported on Form ADV by T••••••• V•••••• M••••••••• L•• (Venture Capital Fund), GAV $40,600,000Fund first reported on Form ADVFundsFactT••••••• J•• A•••••••• F•••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2015T••••••• C••••• F••• I• L• first reported on Form ADV by T••••••• V•••••• M••••••••• L•• (Venture Capital Fund), GAV $3,000,000Fund first reported on Form ADVFundsFactT••••••• C••••• F••• I• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Dec 26, 2013T••••••• T••••••••• F••• I•• L• first reported on Form ADV by T••••••• V•••••• M••••••••• L•• (Venture Capital Fund), GAV $22,500,000Fund first reported on Form ADVFundsFactT••••••• T••••••••• F••• I•• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Dec 26, 2013T••••••• V•••••• M••••••••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Micro VC (probable, 80%, cls-1)venture manager, reported GAV $28.1M across 3 vehicles
Evidence
35 observations from 2 sources